These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19821158)

  • 1. Serum vascular endothelial growth factors a, C and d in human breast tumors.
    Gisterek I; Matkowski R; Lacko A; Sedlaczek P; Szewczyk K; Biecek P; Halon A; Staszek U; Szelachowska J; Pudelko M; Bebenek M; Harlozinska-Szmyrka A; Kornafel J
    Pathol Oncol Res; 2010 Sep; 16(3):337-44. PubMed ID: 19821158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
    Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
    World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
    Zajkowska M; Lubowicka E; Fiedorowicz W; Szmitkowski M; Jamiołkowski J; Ławicki S
    Pathol Oncol Res; 2019 Oct; 25(4):1477-1486. PubMed ID: 30387014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
    Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
    J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
    Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
    Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
    Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
    Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
    Kumar NP; Banurekha VV; Nair D; Babu S
    PLoS One; 2016; 11(1):e0146318. PubMed ID: 26727122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
    Goon PK; Lip GY; Stonelake PS; Blann AD
    Neoplasia; 2009 Aug; 11(8):771-9. PubMed ID: 19649207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer.
    Hoar FJ; Lip GY; Belgore F; Stonelake PS
    Int J Biol Markers; 2004; 19(3):229-35. PubMed ID: 15503825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
    Rykala J; Przybylowska K; Majsterek I; Pasz-Walczak G; Sygut A; Dziki A; Kruk-Jeromin J
    Pathol Oncol Res; 2011 Dec; 17(4):809-17. PubMed ID: 21560015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.
    Vizio B; Novarino A; Giacobino A; Cristiano C; Prati A; Brondino G; Ciuffreda L; Bellone G
    Cancer Sci; 2010 Nov; 101(11):2448-54. PubMed ID: 20950371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
    Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
    Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum concentrations of vascular endothelial growth factor (VEGF) in breast cancer patients.
    Hodorowicz-Zaniewska D; Kibil W; Małek A; Szpor J; Kulig J; Sztefko K
    Pol J Pathol; 2012 Dec; 63(4):255-60. PubMed ID: 23359195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
    Tsirlis TD; Kostakis A; Papastratis G; Masselou K; Vlachos I; Papachristodoulou A; Nikiteas NI
    J Surg Oncol; 2010 Nov; 102(6):699-703. PubMed ID: 20672317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer.
    Lissoni P; Fugamalli E; Malugani F; Ardizzoia A; Secondino S; Tancini G; Gardani GS
    Int J Biol Markers; 2000; 15(4):308-11. PubMed ID: 11192826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of mRNA expression of vascular endothelial growth factor-(A, C, D) genes and its effect on prognosis of breast cancer].
    Zhang GH; Zeng Y; Yang WT; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):473-7. PubMed ID: 17069700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D.
    Sun R; Wang X; Li X
    Med Sci Monit; 2015 Jul; 21():2105-9. PubMed ID: 26191775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
    Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
    Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.